相关实验视频

Updated: Jun 3, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

在矿中探索CD200作为COVID-19的治疗点

Vladimir Perovic1, Sanja Glisic1, Milena Veljkovic2

  • 1Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, 11001 Belgrade, Serbia.

Microorganisms
|June 27, 2024
PubMed
概括

研究人员使用信息光谱法 (ISM) 确定了SARS-CoV-2尖端蛋白 (SP) 上的保存区域. 该地区是开发针对所有COVID-19变种有效的疫苗和治疗方法的有希望的目标.

关键词:
CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD200 CD2 CD2 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD3 CD4 CD2 CD2 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD2 CD2 CD3 CD2 CD2 CD2 CD2 CD3 CD2 is included included included included included在 COVID-19 疫情中,这就是SARS-CoV-2病毒.治疗目标是治疗的目标.疫苗 疫苗 疫苗 疫苗变种变种的变种

更多相关视频

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

7.9K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

551

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...